These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29181659)

  • 21. Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study.
    Makino H; Haneda M; Babazono T; Moriya T; Ito S; Iwamoto Y; Kawamori R; Takeuchi M; Katayama S;
    Hypertens Res; 2008 Apr; 31(4):657-64. PubMed ID: 18633177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visit-to-visit variability in systolic blood pressure predicts development and progression of diabetic nephropathy, but not retinopathy, in patients with type 2 diabetes.
    Takao T; Matsuyama Y; Yanagisawa H; Kikuchi M; Kawazu S
    J Diabetes Complications; 2014; 28(2):185-90. PubMed ID: 24332763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of blood pressure level over a three years period in non-insulin dependent diabetic subjects according to their microalbuminuria].
    Mayaudon H; Bauduceau B; Ducorps M; Belmejdoub G; Poirier JM
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1045-9. PubMed ID: 8949376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes.
    Porrini E; Ruggenenti P; Mogensen CE; Barlovic DP; Praga M; Cruzado JM; Hojs R; Abbate M; de Vries AP;
    Lancet Diabetes Endocrinol; 2015 May; 3(5):382-91. PubMed ID: 25943757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolated high home systolic blood pressure in patients with type 2 diabetes is a prognostic factor for the development of diabetic nephropathy: KAMOGAWA-HBP study.
    Kitagawa N; Ushigome E; Tanaka T; Hasegawa G; Nakamura N; Ohnishi M; Tsunoda S; Ushigome H; Yokota I; Kitagawa N; Hamaguchi M; Asano M; Yamazaki M; Fukui M
    Diabetes Res Clin Pract; 2019 Dec; 158():107920. PubMed ID: 31711859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphism of the aldosterone synthase gene is not associated with progression of diabetic nephropathy, but associated with hypertension in type 2 diabetic patients.
    Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
    Nephrology (Carlton); 2008 Dec; 13(6):492-9. PubMed ID: 18771471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between diabetic retinopathy and diabetic nephropathy in a population-based study in Korea (KNHANES V-2, 3).
    Lee WJ; Sobrin L; Lee MJ; Kang MH; Seong M; Cho H
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6547-53. PubMed ID: 25205863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between ankle-brachial index and microalbuminuria in type 2 diabetes mellitus.
    Makhdoomi K; Mohammadi A; Yekta Z; Aghasi MR; Zamani N; Vossughian S
    Iran J Kidney Dis; 2013 May; 7(3):204-9. PubMed ID: 23689152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Microalbuminuria and diabetic nephropathy. Detection and correlation with other degenerative complications].
    Thivolet C; Ayzac L; Simonet C; Rebattu B; Bernard P; Tourniaire J
    Presse Med; 1990 Jun; 19(23):1075-80. PubMed ID: 2141408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nephropathy, but not Angiographically Proven Retinopathy, is Associated with Neutrophil to Lymphocyte Ratio in Patients with Type 2 Diabetes.
    Ciray H; Aksoy AH; Ulu N; Cizmecioglu A; Gaipov A; Solak Y
    Exp Clin Endocrinol Diabetes; 2015 May; 123(5):267-71. PubMed ID: 25853704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between socioeconomic status and renal function in a population of German patients with diabetic nephropathy treated at a tertiary centre.
    Wolf G; Busch M; Müller N; Müller UA
    Nephrol Dial Transplant; 2011 Dec; 26(12):4017-23. PubMed ID: 21493815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy.
    Li C; Gu Q
    Nephrology (Carlton); 2009 Aug; 14(5):514-20. PubMed ID: 19207863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes.
    Bouchi R; Babazono T; Yoshida N; Nyumura I; Toya K; Hayashi T; Hanai K; Tanaka N; Ishii A; Iwamoto Y
    Hypertens Res; 2010 Oct; 33(10):1000-3. PubMed ID: 20613763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dyslipidemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy].
    Martínez-Castelao A; Ramos R; González MT; Castiñeiras MJ
    Nefrologia; 2002; 22 Suppl 1():51-8. PubMed ID: 11987671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk factors for contrast nephropathy in diabetic patients undergoing cardioangiography].
    Ogi M; Iwase N; Kitamura T; Sawanobori T; Fujimaki S; Kuramochi M; Fujita T; Yokoyama H; Tomosugi N; Takabatake T
    Nihon Jinzo Gakkai Shi; 1993 Feb; 35(2):161-70. PubMed ID: 8315879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of incipient nephropathy in type 2 diabetes mellitus.
    Lemley KV; Abdullah I; Myers BD; Meyer TW; Blouch K; Smith WE; Bennett PH; Nelson RG
    Kidney Int; 2000 Sep; 58(3):1228-37. PubMed ID: 10972685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between reduced ADAMTS13 and diabetic nephropathy.
    Taniguchi S; Hashiguchi T; Ono T; Takenouchi K; Nakayama K; Kawano T; Kato K; Matsushita R; Nagatomo M; Nakamura S; Nakashima T; Maruyama I
    Thromb Res; 2010 Jun; 125(6):e310-6. PubMed ID: 20307901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.